Skip to main content

Animations

MJFF Publications

6971 - 6980 of 9140 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2019
  • 2014
  • 2013
  • 2024
  • 2022
  • 2026
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Fatigue brain network functional connectivity in Parkinson’s disease
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.06.001
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Genome-wide association study of neuropathological features in Lewy body disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaf105
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27728
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011
    Citation Count: 50
  • Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”
    2013
    Summary Details
    RESTRICTED
    Title: Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.09.042
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein
    Journal Name: Chemistry – A European Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/chem.202303921
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26469
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Cortico-cortical paired associative stimulation increases SMA-M1 facilitation in tremor-dominant Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2026.2111928
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.14068
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202413052
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.